Thermo Fisher Scientific Net Income (NCI) increased by 25.0% to $5.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $4.00M to $5.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates that the company's majority-owned subsidiaries are generating more profit for their minority partners, which reduces the net income available to the parent company's shareholders.
This metric represents the portion of a subsidiary's net income that is attributable to minority shareholders who hold a...
Standard accounting line item for any company with partially owned consolidated subsidiaries.
minority_interest| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $1.00M | $5.00M | $4.00M | $3.00M | $3.00M | $1.00M | -$20.00M | $4.00M | $6.00M | $0.00 | $4.00M | $5.00M |
| QoQ Change | — | +0.0% | +400.0% | -20.0% | -25.0% | +0.0% | -66.7% | <-999% | +120.0% | +50.0% | -100.0% | — | +25.0% |
| YoY Change | — | — | — | +300.0% | +200.0% | -40.0% | -75.0% | -766.7% | +33.3% | +500.0% | +100.0% | +0.0% | +25.0% |